Diary - News
All news Kuste Biopharma welcomes a new member of the board and launches its first clinical trial
Lyon (69), 9 November 2020. The French startup, specialised in inflammatory diseases, is proud to expand its reach by welcoming a new member, Elmar Schnee, in its strategic committee. An important step for the development of the company, after the recent closing of a relevant financial round and the launch of its first clinical study.
